Filing Details
- Accession Number:
- 0001062993-24-006058
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-08 18:29:55
- Reporting Period:
- 2024-03-06
- Accepted Time:
- 2024-03-08 18:29:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1850119 | Century Therapeutics Inc. | IPSC | Biological Products, (No Disgnostic Substances) (2836) | 842040295 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1867310 | Adrienne Farid | C/O Century Therapeutics, Inc. 25 N 38Th Street, 11Th Floor Philadelphia PA 19104 | Chief Operations Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-06 | 30,684 | $1.03 | 144,833 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-06 | 30,684 | $4.96 | 114,149 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-03-07 | 22,831 | $1.03 | 136,980 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-07 | 22,831 | $5.14 | 114,149 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-03-06 | 30,684 | $0.00 | 30,684 | $1.03 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-03-07 | 22,831 | $0.00 | 22,831 | $1.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 191,486 | 2029-07-17 | No | 4 | M | Direct | |
| 168,655 | 2029-07-17 | No | 4 | M | Direct |
Footnotes
- The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $5.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.87 to $5.48, inclusive.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
